Calix price target raised to $85 from $65 at Rosenblatt

Rosenblatt analyst Mike Genovese raised the firm’s price target on Calix (CALX) to $85 from $65 and keeps a Buy rating on the shares following the Q3 report. The company’s “strong performance” was driven by competitive displacements against multiple industry players since Calix “has superior products and strategy versus all the competitors,” the analyst tells investors in a research note. The firm believes management continues to keep guidance in a place that can be exceeded. Calix is “very likely to continue beating and raising,” contends Rosenblatt.